John Salsman to Aged, 80 and over
This is a "connection" page, showing publications John Salsman has written about Aged, 80 and over.
Connection Strength
0.499
-
Vergo MT, Whyman J, Li Z, Kestel J, James SL, Rector C, Salsman JM. Assessing Preparatory Grief in Advanced Cancer Patients as an Independent Predictor of Distress in an American Population. J Palliat Med. 2017 01; 20(1):48-52.
Score: 0.083
-
Salsman JM, Beaumont JL, Wortman K, Yan Y, Friend J, Cella D. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. Support Care Cancer. 2015 May; 23(5):1355-64.
Score: 0.073
-
Salsman JM, Lai JS, Hendrie HC, Butt Z, Zill N, Pilkonis PA, Peterson C, Stoney CM, Brouwers P, Cella D. Assessing psychological well-being: self-report instruments for the NIH Toolbox. Qual Life Res. 2014 Feb; 23(1):205-15.
Score: 0.066
-
Salsman JM, Butt Z, Pilkonis PA, Cyranowski JM, Zill N, Hendrie HC, Kupst MJ, Kelly MA, Bode RK, Choi SW, Lai JS, Griffith JW, Stoney CM, Brouwers P, Knox SS, Cella D. Emotion assessment using the NIH Toolbox. Neurology. 2013 Mar 12; 80(11 Suppl 3):S76-86.
Score: 0.065
-
Salsman JM, Garcia SF, Lai JS, Cella D. Have a little faith: measuring the impact of illness on positive and negative aspects of faith. Psychooncology. 2012 Dec; 21(12):1357-61.
Score: 0.059
-
Salsman JM, Yost KJ, West DW, Cella D. Spiritual well-being and health-related quality of life in colorectal cancer: a multi-site examination of the role of personal meaning. Support Care Cancer. 2011 Jun; 19(6):757-64.
Score: 0.053
-
Salsman JM, Pavlik E, Boerner LM, Andrykowski MA. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer. Prev Med. 2004 Aug; 39(2):315-22.
Score: 0.036
-
Moskowitz JT, Cheung EO, Snowberg KE, Verstaen A, Merrilees J, Salsman JM, Dowling GA. Randomized controlled trial of a facilitated online positive emotion regulation intervention for dementia caregivers. Health Psychol. 2019 May; 38(5):391-402.
Score: 0.025
-
Beaumont JL, Salsman JM, Diaz J, Deen KC, McCann L, Powles T, Hackshaw MD, Motzer RJ, Cella D. Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma. Cancer. 2016 Apr 01; 122(7):1108-15.
Score: 0.020
-
Cessna JM, Jim HS, Sutton SK, Asvat Y, Small BJ, Salsman JM, Zachariah B, Fishman M, Field T, Fernandez H, Perez L, Jacobsen PB. Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients. J Psychosom Res. 2016 Feb; 81:9-13.
Score: 0.020